Skip to content

Bioventus BVS Net Income

Net Income at other companies

Stryker logo
StrykerSYK
$745M+13.9%
Medtronic logo
MedtronicMDT
$1.24B+17.8%
Artivion logo
ArtivionAORT
$1.42M+381%
Globus Medical logo
Globus MedicalGMED
$124.3M+64.7%
Avanos Medical logo
Avanos MedicalAVNS
$5.1M-22.7%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$33.91M+34.7%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's net income?
Bioventus (BVS) reported net income of $3.11M in Q1 2026.
How has Bioventus's net income changed year-over-year?
Bioventus's net income increased by 218.1% year-over-year, from -$2.64M to $3.11M.
What is the long-term trend for Bioventus's net income?
Over 4 years (2021 to 2025), Bioventus's net income has grown at a 14.7% compound annual growth rate (CAGR), from $13.14M to $22.73M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.